toll free: 1800 3070 6727 Email: email@example.com
Lung Cancer patients
Patients with no tissue sample, sick patients or patients reluctant for tissue biopsy
US FDA approved
Detects resistance mutation T790M in EGFR positive patients
A substitute for second biopsy
Sample Requirement: 5 ml of Blood in Streck tubes
Circulating Tumour Cell count
NABL certified laboratory
Reporting time: 2 weeks
Download sample report
Celsee CTC is a USA-FDA approved test for EGFR gene testing. This test is for Lung cancer patients undergoing treatment. It is done through blood and is ideal in cases where tumor block is exhausted and saves the cost and pain of repeated biopsies.
Better understand a patients’ risk for specific health conditions
Prescribe more suitable medications at optimal dosages for patients, as needed.
Suggest early lifestyle and diet interventions to help control or prevent certain health conditions.
Test all NCCN recommended genes of patients tumor type
Test for 100 genes including EGFR, KRAS, PIK3CA, HER2, BRAF in affordable price
Replaces most routine diagnostic tests in Lung Cancer, Ovarian Cancer, Kidney Cancer, Pancreatic Cancer and Colorectal Cancer with superior accuracy.
31% more accurate in identifying cancer driver mutations
Better treatment recommendation
Complementary consultation with your doctor
Best treatment recommendation
Provides information on pathway analysis
Includes Positive Bioscience expert comments and complementary consulation with your doctor
533, Kalbadevi Road,
Mumbai – 400002